Engineering the Future of Living Tissue

VascuBio Innovation combines advanced bioprinting, bioreactor design, and microfluidics to build the next generation of tissue engineering and diagnostic solutions.

Born at McGill University, built for the future of medicine.

Our Core Technologies

Three interconnected platforms driving innovation in regenerative medicine and diagnostics.

3D Bioprinting & Bioreactors

Modular, scalable bioreactor systems designed for precision tissue fabrication, drug screening, and disease modeling.

Vascularized Tissue Engineering

Creating functional, vascularized tissue constructs that bridge the gap between laboratory research and clinical application.

Point-of-Care Diagnostics

Rapid, accessible diagnostic solutions bringing laboratory-grade testing closer to the patient.

10+

Years of Research

3

Core Technology Platforms

8+

Strategic Partners

McGill

University Spin-off

Our Partners & Supporters

Backed by leading academic, government, and industry partners.

Ready to Collaborate?

Whether you're exploring partnerships, research collaboration, or career opportunities — let's talk.

Get in Touch